Dr. Lekshmi r.Nath - Non alcoholic fatty liver -hepatocellular carcinoma - Women Researcher Award

Amrita Vishwa vidyapeetham - India

Author Profile 

SCOPUS

ORCID

Early academic pursuits 🎓

Dr. Lekshmi r.Nath embarked on her academic journey in pharmaceutical sciences with a b.pharm degree from mahatma gandhi university, india. her passion for natural products and their medicinal properties led her to pursue an m.pharm in pharmacognosy from rajiv gandhi university of health sciences. she further specialized in biotechnology, earning her ph.d. from the rajiv gandhi centre for biotechnology, kerala, where her research focused on evaluating the anticancer effects of active principles from solanum nigrum linn and chromolaena odorata.

Professional endeavors 🏢

currently an associate professor in the department of pharmacognosy at the amrita school of pharmacy, dr. lekshmi has established herself as a dedicated educator and researcher. her professional journey is marked by her contributions to the field of pharmacognosy, particularly in the exploration of natural products for therapeutic applications. her teaching and mentorship have influenced many students and researchers in the field of pharmaceutical sciences.

Contributions and research focus 🔬

dr. lekshmi's research is centered on the discovery and development of natural products with therapeutic potential. her ph.d. research led to the identification of uttroside b, a compound with significant anticancer properties, particularly against hepatocellular carcinoma. her work extends Non alcoholic fatty liver -hepatocellular carcinoma to both in vitro and in vivo studies, providing a strong foundation for the therapeutic application of natural products. her innovative approach to pharmacognosy continues to contribute valuable insights into the field.

Accolades and recognition 🏅

dr. lekshmi's research has been recognized globally, particularly her work on uttroside b, which has received both u.s. and canadian patents. the significance of her findings was further acknowledged when the fda granted orphan drug designation to uttroside b for the treatment of Non alcoholic fatty liver -hepatocellular carcinoma hepatocellular carcinoma. these accolades underscore her impact in the field of cancer research and her contribution to the development of novel therapeutics.

Impact and influence 🌍

through her research, dr. lekshmi has made a profound impact on the field of pharmacognosy and cancer therapeutics. her discovery of Non alcoholic fatty liver -hepatocellular carcinoma uttroside b offers a new avenue for the treatment of hepatocellular carcinoma, potentially improving outcomes for patients with this challenging disease. her work not only advances scientific knowledge but also has the potential to make a tangible difference in the lives of those affected by cancer.

Legacy and future contributions 🔮

dr. lekshmi's legacy is rooted in her pioneering research on natural products and their application in cancer therapy. her work on uttroside b sets the stage for future research and development in the field, with the potential to lead to new treatments for cancer. as she continues her work, dr. lekshmi is poised to make further contributions to the understanding and use of natural products in medicine, inspiring future generations of researchers.

Notable Publications

Dr. Lekshmi r.Nath – Non alcoholic fatty liver -hepatocellular carcinoma – Women Researcher Award